LOCUS       QTZ54078                1135 aa            linear   VRL 20-APR-2021
DEFINITION  surface glycoprotein, partial [Severe acute respiratory syndrome
            coronavirus 2].
ACCESSION   QTZ54078
VERSION     QTZ54078.1
DBSOURCE    accession MW974444.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1  (residues 1 to 1135)
  AUTHORS   Deng,X., Garcia-Knight,M.A., Khalid,M.M., Servellita,V., Wang,C.,
            Morris,M.K., Sotomayor-Gonzalez,A., Glasner,D.R., Reyes,K.R.,
            Gliwa,A.S., Reddy,N.P., Sanchez San Martin,C., Federman,S.,
            Cheng,J., Balcerek,J., Taylor,J., Streithorst,J.A., Miller,S.,
            Kumar,G.R., Sreekumar,B., Chen,P.Y., Schulze-Gahmen,U., Taha,T.Y.,
            Hayashi,J., Simoneau,C.R., McMahon,S., Lidsky,P.V., Xiao,Y.,
            Hemarajata,P., Green,N.M., Espinosa,A., Kath,C., Haw,M., Bell,J.,
            Hacker,J.K., Hanson,C., Wadford,D.A., Anaya,C., Ferguson,D.,
            Lareau,L.F., Frankino,P.A., Shivram,H., Wyman,S.K., Ott,M.,
            Andino,R. and Chiu,C.Y.
  TITLE     Transmission, infectivity, and antibody neutralization of an
            emerging SARS-CoV-2 variant in California carrying a L452R spike
            protein mutation
  JOURNAL   medRxiv (2021)
   PUBMED   33758899
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 1135)
  AUTHORS   Chiu,C.Y., Deng,X., Wang,C., Servellita,V., Sotomayor-Gonzalez,A.,
            Wyman,S.K., Anaya,C., IDLB COVIDNet,C.D.P.H. and COVID Tracker
            Consortium,C.Z.B.
  TITLE     Direct Submission
  JOURNAL   Submitted (19-APR-2021) Laboratory Medicine, University of
            California, San Francisco, 185 Berry Street, Box 0134, San
            Francisco, CA 94107, USA
COMMENT     Method: conceptual translation.
FEATURES             Location/Qualifiers
     source          1..1135
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="SARS-CoV-2/human/USA/CA-UCSF-UC852/2020"
                     /isolation_source="nasopharyngeal swab"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
                     /geo_loc_name="USA"
                     /collection_date="2020-12-23"
     Protein         <1..1135
                     /product="surface glycoprotein"
     Region          <12..112
                     /region_name="CoV_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of coronavirus
                     Spike (S) proteins; cl40465"
                     /db_xref="CDD:477362"
     Region          183..403
                     /region_name="SARS-CoV-2_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of severe
                     acute respiratory syndrome coronavirus 2 Spike (S)
                     protein; cd21480"
                     /db_xref="CDD:394827"
     Site            order(183,219,243..245,248,252,256,258,275,378..379,383)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(231..232,234,236,238..240,242,244,246..248,251..252,
                     254,290..292,377,379,381)
                     /site_type="other"
                     /note="cryptic epitope [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(279,308,311,315,317..318,337,348..349,351,355,358,
                     360,362..364,367)
                     /site_type="other"
                     /note="receptor binding site [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            300..370
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394827"
     Region          405..1070
                     /region_name="SARS-CoV-like_Spike_SD1-2_S1-S2_S2"
                     /note="SD-1 and SD-2 subdomains, the S1/S2 cleavage
                     region, and the S2 fusion subunit of the spike (S)
                     glycoprotein from SARS-CoV-2 (COVID-19) and related
                     betacoronaviruses in the B lineage; cd22378"
                     /db_xref="CDD:411965"
     Site            order(465,478,519,571,579,663,936,960,996,1020,1035,1056)
                     /site_type="other"
                     /note="N-linked glycosylation sites [posttranslational
                     modification]"
                     /db_xref="CDD:411965"
     Site            order(534..538,540,545..550,552..571)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411965"
     Site            650..668
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411965"
     Site            678..695
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411965"
     Region          780..845
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411965"
     Region          1024..1065
                     /region_name="heptad repeat 2"
                     /note="heptad repeat 2 [structural motif]"
                     /db_xref="CDD:411965"
     CDS             1..1135
                     /gene="S"
                     /coded_by="MW974444.1:<21941..25349"
                     /codon_start=2
ORIGIN      
        1 pxxxxxyhkn nkscmesefr vyssannctf eyvsqpflmd legxxxxxxx xxxxxxxxxx
       61 xxxxxxxxxx xxxxxrdlpq gfsaleplvd lpiginitrf qtllalhrsy ltpgdsssgw
      121 txxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx
      181 xxqptesivr fpnitnlcpf gevfnatrfa svyawnrkri sncvadysvl ynsasfstfk
      241 cygvsptkln dlcftnvyad sfvirgdevr qiapgqtgki adynyklpdd ftgcviawns
      301 nnldskvggn ynyryrlfrk snlkpferdi steiyqagst pcngvegfnc yfplqsygfq
      361 ptngvgyqpy rvvvlsfell hapatvcgpk kstnlvknkc vnfnfngltg tgvltesnkk
      421 flpfqqfgrd iadttdavrd pqtleildit pcsfggvsvi tpgtntsnqv avlyqgvnct
      481 evpvaihadq ltptwrvyst gsnvfqtrag cligaehvnn syecdipiga gicasyqtqt
      541 nsprrarsva sqsiiaytms lgaensvays nnsiaiptnf tisvtteilp vsmtktsvdc
      601 tmyicgdste csnlllqygs fctqlnralt giaveqdknt qevfaqvkqi yktppikdfg
      661 gfnfsqilpd pskpskrsfi edllfnkvtl adagfikqyg dclgdiaard licaqkfngl
      721 tvlpplltde miaqytsall agtitsgwtf gagaalqipf amqmayrfng igvtqnvlye
      781 nqklianqfn saigkiqdsl sstasalgkl qdvvnqnaqa lntlvkqlss nfgaissvln
      841 dilsrldkve aevqidrlit grlqslqtyv tqqliraaei rasanlaatk msecvlgqsk
      901 rvdfcgkgyh lmsfpqsaph gvvflhvtyv paqeknftta paichdgkah fpregvfvsn
      961 gthwfvtqrn fyepqiittd ntfvsgncdv vigivnntvy dplqpeldsf keeldkyfkn
     1021 htspdvdlgd isginasvvn iqkeidrlne vaknlnesli dlqelgkyeq yikwpwyiwl
     1081 gfiagliaiv mvtimlccmt sccsclkgcc scgscckfde ddsepvlkgv klhyt
//

